Previous 10 | Next 10 |
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note that in the second bullet, the time of the Morgan Stanley presentation should be 1:35 pm ET, not 8:10 am ET as previously stated. The correct...
SEATTLE, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming investor conferences: 2023 Wells Fargo Healthcare Conference in Boston on Friday, Sep...
2023-09-01 10:00:00 ET There is some good news and bad news for fans of Cathie Wood. The good news for the co-founder CEO of the Ark Invest family of exchange-traded funds (ETFs) is that her largest fund -- with more than $9 billion in assets -- is rolling in 2023. It's up 40% so far this y...
2023-07-22 00:15:03 ET Summary Accolade is experiencing strong demand due to rising healthcare costs and employers seeking ways to reduce expenses. The company's proprietary technology platform and health assistants provide personalized benefits and health support, leading to sign...
2023-07-20 15:56:18 ET Summary I maintain a buy rating for ACCD as I expect growth reacceleration in FY25 which will drive valuation upwards. ACCD's management has raised revenue expectations for FY24 and reiterated long-term revenue targets. Potential risks include rising int...
2023-06-30 18:42:01 ET Healthcare benefits navigator Accolade 's (NASDAQ: ACCD) stock won the best accolade possible on the market, with a big share price move upwards from happy investors. This followed the release of the company's latest set of quarterly earnings. At the end of tr...
2023-06-29 19:23:04 ET Accolade, Inc. (ACCD) Q1 2024 Earnings Conference Call June 29, 2023, 04:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Health Officer Conference Call Participant...
2023-06-29 16:10:29 ET Accolade press release ( NASDAQ: ACCD ): Q1 GAAP EPS of -$0.52 beats by $0.09 . Revenue of $93.23M (+9.0% Y/Y) beats by $2.95M . Q2 Outlook: Revenue between $93 million and $95 million Adjusted EBITDA between $(11) million and $(1...
Accolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024 SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2023. “Our consistently strong financi...
2023-06-23 15:22:26 ET As the end of the second quarter draws near, a range of notable companies are set to release their earnings reports next week. Leading the pack is Nike ( NYSE: NKE ), the footwear and sports apparel giant. Elsewhere, chip makers Micron Technology ( NASDA...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...